Insulin-inspired hippocampal neuron–targeting technology for protein drug delivery
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2407936121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Noriyasu Kamei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Delivery Systems, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Chuo-ku, Kobe, Hyogo 650-8586, Japan. Hauptthemen laut MEDLINE: Hippocampus, Neurons, Insulin, Drug Delivery Systems. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Takeda Science Foundation (TSF), Mochida Memorial Foundation for Medical and Pharmaceutical Research ( ).
Abstract (Originalsprache)
Hippocampal neurons can be the first to be impaired with neurodegenerative disorders, including Alzheimer’s disease (AD). Most drug candidates for causal therapy of AD cannot either enter the brain or accumulate around hippocampal neurons. Here, we genetically engineered insulin-fusion proteins, called hippocampal neuron–targeting (Ht) proteins, for targeting protein drugs to hippocampal neurons because insulin tends to accumulate in the neuronal cell layers of the hippocampus. In vitro examinations clarified that insulin and Ht proteins were internalized into the cultured hippocampal neurons through insulin receptor–mediated macropinocytosis. Cysteines were key determinants of the delivery of Ht proteins to hippocampal neurons, and insulin B chain mutant was most potent in delivering cargo proteins. In vivo accumulation of Ht proteins to hippocampal neuronal layers occurred after intracerebroventricular administration. Thus, hippocampal neuron–targeting technology can provide great help for developing protein drugs against neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Drug Delivery Systems, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Chuo-ku, Kobe, Hyogo 650-8586, Japan.
ORCID-Profile: Noriyasu Kamei
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Takeda Science Foundation (TSF)
- Mochida Memorial Foundation for Medical and Pharmaceutical Research ( )
Zitieren
APA
Kamei, N., Ikeda, K., Ohmoto, Y., Fujisaki, S., Shirata, R., Maki, M., Miyata, M., Miyauchi, Y., Nishiyama, N., Yamada, M., Ohigashi, Y., & Takeda-Morishita, M. (2024). Insulin-inspired hippocampal neuron–targeting technology for protein drug delivery. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2407936121
Vancouver
Kamei N, Ikeda K, Ohmoto Y, Fujisaki S, Shirata R, Maki M, et al. Insulin-inspired hippocampal neuron–targeting technology for protein drug delivery. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2407936121
BibTeX
@article{Kamei2024,
author = {Kamei, Noriyasu and Ikeda, Kento and Ohmoto, Yuka and Fujisaki, Seita and Shirata, Ryusei and Maki, Maya and Miyata, Mika and Miyauchi, Yuki and Nishiyama, Nanaka and Yamada, Mana and Ohigashi, Yuna and Takeda-Morishita, Mariko},
title = {Insulin-inspired hippocampal neuron–targeting technology for protein drug delivery},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2407936121}
}
EUVIMED